2B7J:F:F-iShares MSCI World SRI UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 8.413

Change

-0.24 (-2.76)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.74 (-1.42%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-13.56 (-2.41%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.79 (-1.38%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.23 (-1.47%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.60 (-1.55%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-1.29 (-1.30%)

USD 51.63B
0ZC:F Zscaler Inc

-3.30 (-1.48%)

USD 37.92B
BSND:F Danone SA

+0.20 (+1.39%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-1.66 (-1.29%)

USD 24.77B

ETFs Containing 2B7J:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.79% 29% F 44% F
Dividend Return -4.54% 18% F 1% F
Total Return -10.33% 13% F 33% F
Trailing 12 Months  
Capital Gain 2.94% 47% F 58% F
Dividend Return -3.61% 13% F 1% F
Total Return -0.68% 30% F 45% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.54% 58% F 58% F
Dividend Return 6.48% 54% F 50% F
Total Return -0.06% 4% F N/A F
Risk Return Profile  
Volatility (Standard Deviation) 9.74% 68% D+ 92% A
Risk Adjusted Return 66.52% 67% D+ 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.